Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Dec 15, 2006

Sanofi-aventis statement regarding U.S. FDA joint advisory committee recommendation for KETEK® (telithromycin)
Dec 12, 2006

New study shows LOVENOX® (enoxaparin sodium injection) is more effective than unfractionated heparin (UFH) for lowering the risk of venous thromboembolism (VTE) in patients with acute ischemic stroke

The PREVAIL study showed that in acute ischemic stroke patients treated with Lovenox, the risk of having a VTE was lowered by a significant 43% with no statistically significant increase in clinically important bleedings when compared to UFH
Dec 8, 2006

Rimonabant update in the United States
Dec 5, 2006

New data shows Rimonabant benefited patients with type 2 diabetes by improving blood sugar control, reducing weight and acting on other cardiometabolic risk factors

First Rimonabant Trial with HbA1c as a Primary Endpoint
Nov 27, 2006

Sanofi Pasteur Completes Shipment of 50 Million Doses of Influenza Vaccine

Sanofi pasteur able to produce additional vaccine to meet customer demand

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.